A New Corporate Image for AmorChem

April 2, 2019 Off By BusinessWire

MONTREAL–(BUSINESS WIRE)–AmorChem, a leading venture fund dedicated to creating the next
generation of biotech companies derived from academic research,
introduced its rebranding this week. The fund is proud to present an
entirely rethought visual image, through a new logo and website, as well
as a move to new offices. The design of the new fund brand was propelled
by a desire to reflect the unique role played by the fund in its
ecosystem. Accordingly, the fresh logo, website and offices embody
AmorChem’s vision: building an active and collaborative community of
biotech start-ups from academic research and fostering a new generation
of passionate science entrepreneurs.

Since its launch in 2011, the implementation of the fund’s vision has
resulted in the successful financing of over 25 research programs in
academia and the accelerated creation of several biotech companies, each
with its own groundbreaking therapeutic paradigm.

“At AmorChem, we believe in the power of collaboration to help us
transform innovative academic research into next generation biotech
companies. A key goal of our rebranding was the creation of a physical
space favourable to the flow of ideas, allowing us to welcome the
passionate academics, interns, technology transfer officers,
entrepreneurs, limited partners and venture investors who help us
achieve our collective objectives,” explains Elizabeth Douville, founder
and managing partner.

“We focus our core expertise in the translational steps that accelerate
drug discovery and development across a broad spectrum of disease areas.
Our new website highlights the diversity of innovative science in which
we invest as well as the creative and dedicated people who have
contributed and continue to help us to become the premier early stage
venture fund in Canada,” says Ines Holzbaur, founder and managing
partner.

“AmorChem essentially builds a bridge over the gap between promising
academic research and successful biotech start-ups. The new shape of the
AmorChem logo provides a visual reference to this bridge as well as a
nod to the scientific world which lights the first spark,” adds Maxime
Ranger, general partner.

The new website and the logo can now be seen at www.amorchem.com.
The team has moved to 4 Westmount Square, Suite 160, Westmount (Québec),
H3Z 2S6.

About AmorChem

AmorChem is a leading early stage venture capital fund launched in 2011
in Montreal. The AmorChem team utilizes its deep understanding of
fundamental science to uncover its therapeutic potential and focuses its
core expertise in translational research to accelerate therapeutic drug
discovery and development across a broad spectrum of disease areas. The
fund capitalises on both its venture capital expertise and its
entrepreneurial experience to spark the creation of start-up companies
and help shape them into the next generation of biotech companies. With
over $85M under management, AmorChem has financed over 25 university
projects and started up several biotechnology companies from the fruits
of this innovative research.